{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:48:24Z","timestamp":1761598104510,"version":"build-2065373602"},"reference-count":246,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.phrs.2019.104371","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T19:58:56Z","timestamp":1565639936000},"page":"104371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cytotoxicity models of Huntington\u2019s disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies"],"prefix":"10.1016","volume":"150","author":[{"given":"Edward J.","family":"Calabrese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun N.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannic N.","family":"Hanekamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachna","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Kozumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehana K.","family":"Leak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.104371_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.freeradbiomed.2016.11.045","article-title":"Adaptive responses of neuronal mitochondria to bioenergetics challenges: roles in neuroplasticity and disease resistance","volume":"102","author":"Raefsky","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2019.104371_bib0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2019.104371_bib0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0301-0082(99)00032-5","article-title":"Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington\u2019s diseases","volume":"60","author":"Alexi","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J. Neurochem."},{"issue":"50","key":"10.1016\/j.phrs.2019.104371_bib0025","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1046\/j.1471-4159.1994.63051772.x","article-title":"3-Nitropropionic acid toxicity in the striatum","volume":"63","author":"Wullner","year":"1994","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0306-4522(95)00527-7","article-title":"Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases","volume":"71","author":"Schulz","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2019.104371_bib0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.phrs.2015.12.021","article-title":"Preconditioning is hormesis, Part I: Documentation, dose-response features and mechanistic foundation","volume":"110","author":"Calabrese","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.phrs.2015.12.020","article-title":"Preconditioning is hormesis, Part II: How the conditioning dose mediates protection: dose optimization within temporal and mechanistic frameworks","volume":"110","author":"Calabrese","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/exnr.1996.0042","article-title":"Mitochondrial oxidation in rat hippocampus can be preconditioned by selective chemical inhibition of succinic dehydrogenase","volume":"138","author":"Riepe","year":"1996","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2019.104371_bib0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1006820927262","article-title":"Chemical preconditioning: a cytoprotective strategy","volume":"174","author":"Riepe","year":"1997","journal-title":"Mol. Cell. Biochem."},{"issue":"17-18","key":"10.1016\/j.phrs.2019.104371_bib0055","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.lfs.2008.02.011","article-title":"Chemical preconditioning effect of 3-nitropropionic acid in anesthetized rat heart","volume":"82","author":"Turan","year":"2008","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib0060","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s12272-001-2104-3","article-title":"The mechanism of the late preconditioning effect of 3-nitropropionic acid","volume":"31","author":"Basgut","year":"2008","journal-title":"Arch. Pharm. Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0065","first-page":"706","article-title":"Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats","volume":"60","author":"Kumar","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2019.104371_bib0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2003.09.049","article-title":"Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington\u2019s disease","volume":"994","author":"Saydoff","year":"2003","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0891-5849(03)00317-4","article-title":"Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems","volume":"35","author":"Santamaria","year":"2003","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","article-title":"Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington\u2019s disease","volume":"18","author":"Matthews","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pnpbp.2015.02.005","article-title":"ADIOL protects against 3-NP-induced neurotoxicity in rats: possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions","volume":"60","author":"Hanna","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104371_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2004.09.061","article-title":"Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes","volume":"504","author":"Tunez","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2019.104371_bib0095","doi-asserted-by":"crossref","first-page":"e67658","DOI":"10.1371\/journal.pone.0067658","article-title":"Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats","volume":"8","author":"Colle","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddi422","article-title":"Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy","volume":"15","author":"Davies","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib0110","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1298","article-title":"17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration","volume":"11","author":"Waza","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2019.104371_bib0115","doi-asserted-by":"crossref","first-page":"31652","DOI":"10.1038\/srep31652","article-title":"Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease","volume":"6","author":"Garcia-Miralles","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib0120","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/0269881110364269","article-title":"Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington\u2019s-like symptoms: a comparative study","volume":"25","author":"Kumar","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/01480541003642050","article-title":"Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain","volume":"33","author":"Kumar","year":"2010","journal-title":"Drug Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1091581810365568","article-title":"Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism","volume":"29","author":"Kumar","year":"2010","journal-title":"Int. J. Toxicol."},{"issue":"2B","key":"10.1016\/j.phrs.2019.104371_bib0135","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington\u2019s disease-like symptoms in rats: protective effect of licofelone","volume":"164","author":"Kumar","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuroscience.2014.12.018","article-title":"Neuroprotective effect of hemeoxygenase-1\/glycogen synthase kinase-3 beta modulators in 3-nitropropionic acid-induced neurotoxicity in rats","volume":"287","author":"Khan","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2019.104371_bib0145","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuro.2012.07.007","article-title":"Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats","volume":"33","author":"Menze","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.phrs.2019.104371_bib0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tox.2007.11.003","article-title":"Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity","volume":"244","author":"Ahuja","year":"2008","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.phrs.2019.104371_bib0155","first-page":"672","article-title":"Piroxican attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice","author":"Jadiswami","year":"2014","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.phrs.2019.104371_bib0160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbadis.2012.11.018","article-title":"Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington\u2019s disease","volume":"1832","author":"Sandhir","year":"2013","journal-title":"Biochim. Biphys. Acta"},{"key":"10.1016\/j.phrs.2019.104371_bib0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.physbeh.2015.12.015","article-title":"Spermidine amerliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: possible role of oxidative stress, neuroinflammation, and neurotransmitters","volume":"155","author":"Jamwal","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2019.104371_bib0170","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neuint.2011.07.012","article-title":"The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats","volume":"59","author":"Mahdy","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2019.104371_bib0175","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1007\/s12035-015-9303-2","article-title":"Role of Rho kinase inhibition in the protective effect of fasudil and simvastatin against 3-nitropropionic acid-induced striatal neurodegeneration and mitochondrial dysfunction in rats","volume":"53","author":"Ahmed","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.phrs.2019.104371_bib0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/00207454.2013.872642","article-title":"Neuroprotective activity of l-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum","volume":"124","author":"Thangarajan","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejphar.2013.06.035","article-title":"Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats","volume":"714","author":"Thakur","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib0190","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.lfs.2009.10.001","article-title":"Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity","volume":"85","author":"Kumar","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2019.104371_bib0195","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.fct.2009.07.011","article-title":"Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism","volume":"47","author":"Kumar","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2019.104371_bib0200","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1046\/j.1471-4159.2000.0751709.x","article-title":"Effect of exogenous and endogenous antioxidants on 3-nitropropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington\u2019s disease","volume":"75","author":"La Fontaine","year":"2000","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.phrs.2019.104371_bib0205","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.pnpbp.2011.09.005","article-title":"Melatonin improves 3-nitropropionic acid induced behavioral alterations and neurotrophic factors levels","volume":"35","author":"Tasset","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104371_bib0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuro.2012.10.008","article-title":"Korean red ginseng ameliorates acute 3-nitropropionic acid-induced cochlear damage in mice","volume":"34","author":"Tian","year":"2013","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0215","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10522-016-9646-8","article-title":"Pre- and post-conditioning hormesis in elderly mice, rats, and humans: its loss and restoration","volume":"17","author":"Calabrese","year":"2016","journal-title":"Biogeontology"},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0220","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q(10) and remacemide in transgenic mouse models of Huntington\u2019s disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2013.08.001","article-title":"Possible beneficial effect of peroxisome proliferator-activated receptor (PPAR) \u2013 alpha and gamma agonist against a rat model of oral dyskinesia","volume":"111","author":"Grover","year":"2013","journal-title":"Pharm. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0230","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1006\/exnr.1998.6942","article-title":"Neuroprotective effects of the alpha(2)-adrenoceptor antagonists, (+)-efaroxan and (+\/\u2212)-idazoxan, against quinolinic acid-induced lesions of the rat striatum","volume":"154","author":"Martel","year":"1998","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0235","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0361-9230(03)00141-2","article-title":"Chronic lithium chloride treatment has variable effects on motor behavior and survival of mice transgenic for the Huntington\u2019s disease mutation","volume":"61","author":"Wood","year":"2003","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000084169","article-title":"Treatment with dehydroepiandrosterone prevents oxidative stress induced by 3-nitropropionic acid in synaptosomes","volume":"74","author":"Tunez","year":"2005","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-8993(02)03474-1","article-title":"Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity","volume":"956","author":"Borlongan","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0250","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainres.2005.05.024","article-title":"Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington\u2019s disease","volume":"1050","author":"De Lago","year":"2005","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1179\/1476830511Y.0000000005","article-title":"Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington\u2019s disease-like rat model","volume":"14","author":"Tasset","year":"2011","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13311-014-0304-z","article-title":"Neuroprotective properties of cannabigerol in Huntington\u2019s disease: studies in R6\/2 mice and 3-nitropropionate-lesioned mice","volume":"12","author":"Valdeolivas","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0265","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104371_bib0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.expneurol.2017.03.020","article-title":"2,4-DNP improves motor function, preserves medium spiny neuronal identity, and reduces oxidative stress in a mouse model of Huntington\u2019s disease","volume":"293","author":"Wu","year":"2017","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0275","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.taap.2004.06.023","article-title":"The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview","volume":"202","author":"Calabrese","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yrtph.2011.06.003","article-title":"The hormesis database: the occurrence of hormetic dose responses in the toxicological literature","volume":"61","author":"Calabrese","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2019.104371_bib0285","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3109\/10408444.2013.808172","article-title":"Hormetic mechanisms","volume":"43","author":"Calabrese","year":"2013","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.phrs.2019.104371_bib0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41514-017-0013-z","article-title":"How does hormesis impact biology, toxicology, and medicine?","volume":"3","author":"Calabrese","year":"2017","journal-title":"NPJ Aging Mech. Dis."},{"key":"10.1016\/j.phrs.2019.104371_bib0295","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.envres.2018.12.020","article-title":"Estimating the range of the maximum hormetic stimulatory response","volume":"170","author":"Calabrese","year":"2019","journal-title":"Environ. Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0300","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12017-008-8037-y","article-title":"Hormetic dietary phytochemicals","volume":"10","author":"Son","year":"2008","journal-title":"Neuromol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2019.104371_bib0305","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/10408440802014238","article-title":"An assessment of anxiolytic drug screening tests: hormetic dose responses predominate","volume":"38","author":"Calabrese","year":"2008","journal-title":"Crit. Rev. Toxicol."},{"issue":"6","key":"10.1016\/j.phrs.2019.104371_bib0310","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10408440802014261","article-title":"Modulation of the epileptic seizure threshold: Implications of biphasic dose responses","volume":"38","author":"Calabrese","year":"2008","journal-title":"Crit. Rev. Toxicol."},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/10408440802003991","article-title":"Alzheimer's disease drugs: an application of the hormetic dose-response model","volume":"38","author":"Calabrese","year":"2008","journal-title":"Crit. Rev. Toxiocl."},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib0320","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jnr.24244","article-title":"Hormetic approaches to the treatment of Parkinson's disease: perspectives and possibilities","volume":"96","author":"Calabrese","year":"2018","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0325","first-page":"143","article-title":"Conditioning against the pathology of Parkinson's disease","volume":"1","author":"Leak","year":"2018","journal-title":"Cond. Med."},{"issue":"38","key":"10.1016\/j.phrs.2019.104371_bib0330","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1523\/JNEUROSCI.1867-08.2008","article-title":"Inhibitors of cytochrome C release with therapeutic potential for Huntington\u2019s disease","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0335","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1038\/srep29789","article-title":"VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington\u2019s disease","volume":"6","author":"Diaz-Alonso","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0340","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1074\/jbc.M110.158220","article-title":"Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF-1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104371_bib0345","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1038\/s41598-018-25984-7","article-title":"Organoruthenium(II) complexes ameliorates oxidative stress and impedes the age associated deterioration in Caenorhabditis elegans through JNK-1\/DAF-16 signaling","volume":"8","author":"Devagi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2019.104371_bib0350","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/s41598-017-04990-1","article-title":"Laquinimod treatment in the R6\/2 mouse model","volume":"7","author":"Ellrichmann","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.phrs.2019.104371_bib0355","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbi.2014.01.015","article-title":"Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms","volume":"38","author":"Jang","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2019.104371_bib0360","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.neuint.2004.06.008","article-title":"S-allycysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats","volume":"45","author":"Perez-Severiano","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2019.104371_bib0365","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2007.12.056","article-title":"Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats","volume":"1198","author":"Velloso","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2005.05.028","article-title":"The critical threshold of 3-nitropropionic acid-induced ischemic tolerance in the rat","volume":"1050","author":"Hoshi","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0375","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.mp.4001463","article-title":"Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington\u2019s disease","volume":"9","author":"Senatorov","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104371_bib0380","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(00)00937-X","article-title":"3-Nitropropionic acid preconditioning ameliorate delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils","volume":"283","author":"Kuroiwa","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.104371_bib0385","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainresbull.2012.01.003","article-title":"Probucol modulates oxidative stress and excitotoxicity in Huntington\u2019s disease models in vitro","volume":"87","author":"Colle","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2019.104371_bib0390","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neulet.2008.05.066","article-title":"Preconditioning with NMDA protects against toxicity of 3-nitropropionic acid or glutamate in cultured cerebellar granule neurons","volume":"440","author":"Smith","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.104371_bib0395","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjp.0703869","article-title":"Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo","volume":"132","author":"Pubill","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib0400","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U","article-title":"Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity","volume":"425","author":"Leventhal","year":"2000","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0405","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-160205","article-title":"Oxidative stress and Huntington\u2019s disease: the good, the bad, and the ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J. Huntingtons Dis."},{"issue":"5576","key":"10.1016\/j.phrs.2019.104371_bib0410","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0415","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cmet.2015.05.012","article-title":"A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan","volume":"22","author":"Brandhorst","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2019.104371_bib0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nbd.2015.09.012","article-title":"Protection by dietary restriction in the YAC128 mouse model of Huntington\u2019s disease: relation to genes regulating histone acetylation and HTT","volume":"85","author":"Moreno","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.phrs.2019.104371_bib0425","doi-asserted-by":"crossref","first-page":"e2264","DOI":"10.1371\/journal.pone.0002264","article-title":"A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice","volume":"3","author":"Barger","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104371_bib0430","doi-asserted-by":"crossref","first-page":"H299","DOI":"10.1152\/ajpheart.00744.2013","article-title":"Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and down-regulation of NADPH oxidase","volume":"306","author":"Toth","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2019.104371_bib0435","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/neuro.24.004.2009","article-title":"Resveratrol preserves cerebrovascular density and cognitive function in aging mice","volume":"1","author":"Oomen","year":"2009","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0440","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/acel.12315","article-title":"Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection","volume":"14","author":"Toth","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.phrs.2019.104371_bib0445","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejmech.2015.04.038","article-title":"Synthesis of amphiphilic resveratrol lipoconjugates and evaluation of their anticancer activity towards neuroblastoma SH-SY5Y cell line","volume":"96","author":"Chillemi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2019.104371_bib0450","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.0712162105","article-title":"Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction","volume":"105","author":"Pearson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phrs.2019.104371_bib0455","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/acel.12078","article-title":"Declining signal dependence of Nrf2-MafS-regulated gene expression correlates with aging phenotypes","volume":"12","author":"Rahman","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.phrs.2019.104371_bib0460","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.devcel.2007.12.002","article-title":"Keap1\/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila","volume":"14","author":"Sykiotis","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.phrs.2019.104371_bib0465","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.biocel.2012.04.021","article-title":"Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging","volume":"44","author":"Chapple","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phrs.2019.104371_bib0470","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2015.05.036","article-title":"Oxidative stress response and Nrf2 signaling in aging","volume":"88","author":"Zhang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2019.104371_bib0475","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"12","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.phrs.2019.104371_bib0480","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1089\/ars.2009.2721","article-title":"Nitric oxide in cell survival: a janus molecule","volume":"11","author":"Calabrese","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2019.104371_bib0485","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jnr.23290","article-title":"Reactive response evaluation of primary human astrocytes after methylmercury exposure","volume":"92","author":"Malfa","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0490","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1126\/science.1106653","article-title":"Extension of murine life span by overexpression of catalase targeted to mitochondria","volume":"308","author":"Schriner","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104371_bib0495","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/CIRCULATIONAHA.108.822403","article-title":"Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging","volume":"119","author":"Dai","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2019.104371_bib0500","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/syn.21793","article-title":"4-Hydroxy tempo improves mitochondrial and neurobehavioral deficits in experimental model of Huntington\u2019s disease","volume":"69","author":"Sandhir","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.phrs.2019.104371_bib0505","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jjcc.2015.08.002","article-title":"Cardioprotective mechanism of omega-3 polyunsaturated fatty acids","volume":"67","author":"Endo","year":"2016","journal-title":"J. Cardiol."},{"key":"10.1016\/j.phrs.2019.104371_bib0510","doi-asserted-by":"crossref","DOI":"10.3233\/JHD-180309","article-title":"Possible role of the polyglutamine elongation in evolution of amyloid-related evolvability","author":"Hashimoto","year":"2018","journal-title":"J. Huntingtons Dis."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0515","doi-asserted-by":"crossref","first-page":"e2003693","DOI":"10.1371\/journal.pbio.2003693","article-title":"Reproducibility of preclinical animal research improves with heterogeneity of study samples","volume":"16","author":"Voelkl","year":"2018","journal-title":"PLOS Biol."},{"key":"10.1016\/j.phrs.2019.104371_bib0520","first-page":"263","article-title":"Behaviour and the standardization fallacy","volume":"26","author":"Wurbel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104371_bib0525","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting antioxidants to mitochondria by conjugation to lipophilic cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2019.104371_bib0530","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pnpbp.2012.08.018","article-title":"Enhanced neuroprotective effect in fish oil in combination with quercetin against 3-nitropropionic acid induced oxidative stress in rat brain","volume":"40","author":"Denny Joseph","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104371_bib0535","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1139\/apnm-2013-0262","article-title":"Neuroprotective efficacy of a combination of fish oil and ferulic acid against 3-nitropropionic acid-induced oxidative stress and neurotoxicity in rats: behavioural and biochemical evidence","volume":"39","author":"Denny Joseph","year":"2014","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib0540","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1177\/0271678X17738701","article-title":"A combination antioxidant therapy to inhibit NOX2 and activate Nrf2 decreases secondary brain damage and improves functional recovery after traumatic brain injury","volume":"38","author":"Chandran","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib0545","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCRESAHA.116.307475","article-title":"Pharmacological strategies to retard cardiovascular aging","volume":"118","author":"Alfaras","year":"2016","journal-title":"Circ. Res."},{"issue":"14S","key":"10.1016\/j.phrs.2019.104371_bib0550","article-title":"Huntington\u2019s disease and the heart: electrocardiogram abnormalities suggest cardiac involvement","volume":"84","author":"Stephen","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0555","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2009.08.028","article-title":"Protective effect of hesperidine and naringin against 3-nitropropionic acid induced Huntington\u2019s like symptoms in rats: possible role of nitric oxide","volume":"206","author":"Kumar","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0560","first-page":"63","article-title":"Coordinated cycling of calorie restriction, exercise, and pharmaceuticals to enhance molecular turnover and removal of age-related neurotoxins","volume":"19","author":"Cutler","year":"2015","journal-title":"Appr. Aging Cont."},{"key":"10.1016\/j.phrs.2019.104371_bib0565","first-page":"357","article-title":"Hormesis as a biological hypothesis","volume":"106","author":"Calabrese","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.phrs.2019.104371_bib0570","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","article-title":"Deleterious effects of minocycline in animal models of Parkinsons disease and Huntington\u2019s disease","volume":"19","author":"Diguet","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0575","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.2003.01595.x","article-title":"Compounds acting at the endocannabinoid and\/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington\u2019s disease","volume":"84","author":"Lastres-Becker","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104371_bib0580","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0585","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/glia.20838","article-title":"Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington\u2019s disease","volume":"57","author":"Sagredo","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2019.104371_bib0590","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jnr.22682","article-title":"Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington\u2019s disease","volume":"89","author":"Sagredo","year":"2011","journal-title":"J. Neurosci. Res."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2019.104371_bib0595","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0006-8993(99)01487-0","article-title":"Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions","volume":"834","author":"Maragos","year":"1999","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.phrs.2019.104371_bib0600","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/00001756-200006260-00007","article-title":"Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats","volume":"11","author":"Shear","year":"2000","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0605","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.20450","article-title":"Protective effects of ginseng components in a rodent model of neurodegeneration","volume":"57","author":"Lian","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2019.104371_bib0610","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuropharm.2004.12.013","article-title":"Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats","volume":"48","author":"Kim","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2019.104371_bib0615","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2014.01.048","article-title":"Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease","volume":"264","author":"Chakraborty","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2019.104371_bib0620","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2005.03.053","article-title":"Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum","volume":"1046","author":"Nam","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0625","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/aps.2014.107","article-title":"Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington\u2019s disease","volume":"36","author":"Gao","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0630","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0306-4522(97)00192-9","article-title":"Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats","volume":"81","author":"Guyot","year":"1997","journal-title":"Neuroscience"},{"issue":"15","key":"10.1016\/j.phrs.2019.104371_bib0635","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/00001756-200410250-00015","article-title":"Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo","volume":"15","author":"Lastres-Becker","year":"2004","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0640","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","article-title":"Combination therapy with coenzyme Q(10) and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington\u2019s diseases","volume":"9","author":"Yang","year":"2009","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.phrs.2019.104371_bib0645","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration","volume":"20","author":"Woodruff","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.104371_bib0650","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2008.10.020","article-title":"Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington\u2019s disease","volume":"448","author":"Park","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.104371_bib0655","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2010.01.013","article-title":"Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF","volume":"38","author":"Puerta","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2019.104371_bib0660","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pbb.2014.03.022","article-title":"Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington\u2019s disease","volume":"122","author":"Gupta","year":"2014","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.phrs.2019.104371_bib0665","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1471-4159.2006.03724.x","article-title":"Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington\u2019s disease","volume":"97","author":"Tunez","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104371_bib0670","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12640-012-9336-5","article-title":"Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats","volume":"23","author":"Bortolatto","year":"2013","journal-title":"Neurotox. Res."},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib0675","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3109\/13880209.2014.984856","article-title":"Protective effect of Convolvulus pluricaulis standardized extract and its actions against 3-nitropropionic acid-induced neurotoxicity in rats","volume":"53","author":"Malik","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.phrs.2019.104371_bib0680","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","article-title":"Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms","volume":"21","author":"Kumar","year":"2007","journal-title":"Fund. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2019.104371_bib0685","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s11064-015-1658-2","article-title":"Piperine enhances the protective effect of curcumin against 3-NP induced neurotoxicity: possible neurotransmitters modulation mechanism","volume":"40","author":"Singh","year":"2015","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0690","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neures.2009.01.005","article-title":"Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione in rat: possible role of nitric oxide","volume":"63","author":"Kumar","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.phrs.2019.104371_bib0695","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2004.02.004","article-title":"Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes","volume":"488","author":"Montilla","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib0700","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroscience.2012.02.034","article-title":"Neuroprotective effects of extremely low-frequency electromagnetic fields on a Huntington\u2019s disease rat model: effects on neurotrophic factors and neuronal density","volume":"209","author":"Tasset","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2019.104371_bib0705","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","article-title":"Effect of embelin against 3-nitropropionic acid-induced Huntington\u2019s disease in rats","volume":"77","author":"Dhadde","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0710","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1742-7843.2010.00537.x","article-title":"Protective effects of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats","volume":"107","author":"Kumar","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0715","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1471-4159.2009.06331.x","article-title":"Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid","volume":"111","author":"Lagoa","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104371_bib0720","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.expneurol.2007.06.008","article-title":"Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid","volume":"207","author":"Tozzi","year":"2007","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0725","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1358\/mf.2007.29.1.1063492","article-title":"Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity","volume":"29","author":"Kumar","year":"2007","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2019.104371_bib0730","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.neuint.2011.08.022","article-title":"Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis","volume":"59","author":"Gopinath","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2019.104371_bib0735","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/cjpp-2013-0398","article-title":"The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats","volume":"92","author":"Mahdy","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib0740","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.toxrep.2015.08.004","article-title":"Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats","volume":"2","author":"Kaur","year":"2015","journal-title":"Toxicol. Rep."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2019.104371_bib0745","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2009.04.058","article-title":"Protective effects of rivastigmine against 3-nitropropionic acid-induced Huntington\u2019s disease like symptoms: possible behavioral, biochemical and cellular effects","volume":"615","author":"Kumar","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0750","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11011-016-9929-4","article-title":"Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations \u2013 a pilot study on Huntington\u2019s disease model in rats","volume":"32","author":"Suganya","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.phrs.2019.104371_bib0755","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresbull.2005.09.013","article-title":"Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes","volume":"68","author":"Perez-De La Cruz","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2019.104371_bib0760","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neures.2006.04.018","article-title":"S-allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction","volume":"56","author":"Herrera-Mundo","year":"2006","journal-title":"Neurosci. Res."},{"issue":"9","key":"10.1016\/j.phrs.2019.104371_bib0765","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00210-017-1392-1","article-title":"Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats","volume":"390","author":"Wahdan","year":"2017","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib0770","first-page":"715","article-title":"Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain","volume":"47","author":"Kumar","year":"2009","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.phrs.2019.104371_bib0775","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","article-title":"Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain","volume":"33","author":"Kumar","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"50","key":"10.1016\/j.phrs.2019.104371_bib0780","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10286020902862194","article-title":"Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats","volume":"11","author":"Kumar","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0785","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pbb.2005.10.018","article-title":"Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington\u2019s disease phenotype","volume":"82","author":"Tadros","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2019.104371_bib0790","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.lfs.2006.12.013","article-title":"Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats","volume":"80","author":"Tunez","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2019.104371_bib0795","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.biopha.2018.06.079","article-title":"Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats","volume":"105","author":"Danduga","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2019.104371_bib0800","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neures.2006.05.012","article-title":"Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes","volume":"56","author":"Tunez","year":"2006","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0805","first-page":"261","article-title":"Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors","volume":"9","author":"Maya-Lopez","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0810","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuint.2005.11.011","article-title":"17\u03b2-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington\u2019s disease in ovariectomized rats","volume":"48","author":"Tunez","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2019.104371_bib0815","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11010-015-2561-5","article-title":"Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington\u2019s disease","volume":"410","author":"Mehrotra","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0820","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/01480545.2013.776583","article-title":"Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats","volume":"36","author":"Shivasharan","year":"2013","journal-title":"Drug Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0825","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5214\/ans.0972.7531.220104","article-title":"Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid","volume":"22","author":"Shetty","year":"2015","journal-title":"Ann. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0830","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.neuint.2010.07.005","article-title":"Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system","volume":"57","author":"Sandhir","year":"2010","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0835","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000334273","article-title":"N-acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease","volume":"9","author":"Sandhir","year":"2012","journal-title":"Neurodegen. Dis."},{"key":"10.1016\/j.phrs.2019.104371_bib0840","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainresbull.2005.06.024","article-title":"Neuroprotective effects of nicotine against 3-nitroproionic acid (3-NP)-induced experimental Huntington\u2019s disease in rats","volume":"67","author":"Tariq","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2019.104371_bib0845","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.exger.2017.06.009","article-title":"3-NP-induced Huntington\u2019s-like disease impairs Nrf2 activation without loss of cardiac function in aged rats","volume":"96","author":"Silva-Palacios","year":"2017","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.phrs.2019.104371_bib0850","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ntt.2009.09.003","article-title":"Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats","volume":"32","author":"Al Mutairy","year":"2010","journal-title":"Neurotoxicol. Teratol."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0855","doi-asserted-by":"crossref","first-page":"e0117223","DOI":"10.1371\/journal.pone.0117223","article-title":"Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties","volume":"10","author":"Menze","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2019.104371_bib0860","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cbi.2016.05.020","article-title":"A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington\u2019s disease-like symptoms in Wistar rats","volume":"256","author":"Ramachandran","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0865","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.neuroscience.2006.05.043","article-title":"Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington\u2019s disease","volume":"141","author":"Ryu","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0870","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0014-4886(03)00214-0","article-title":"Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington\u2019s disease","volume":"183","author":"Ryu","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2019.104371_bib0875","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2006.09.006","article-title":"Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity","volume":"25","author":"DeMarch","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib0880","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.neuropharm.2006.06.013","article-title":"The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum","volume":"51","author":"Pintor","year":"2006","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.phrs.2019.104371_bib0885","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2010.02.031","article-title":"Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats","volume":"634","author":"Kalonia","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"33","key":"10.1016\/j.phrs.2019.104371_bib0890","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","article-title":"Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington\u2019s disease mouse model","volume":"102","author":"Nguyen","year":"2005","journal-title":"PNAS"},{"issue":"20","key":"10.1016\/j.phrs.2019.104371_bib0895","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington\u2019s disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0900","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.1085","article-title":"Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington\u2019s disease","volume":"50","author":"Andreassen","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0905","doi-asserted-by":"crossref","first-page":"e16172","DOI":"10.1371\/journal.pone.0016172","article-title":"Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington\u2019s disease","volume":"6","author":"Ellrichmann","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0910","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/hmg\/ddq460","article-title":"ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington\u2019s disease","volume":"20","author":"Maher","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"15","key":"10.1016\/j.phrs.2019.104371_bib0915","first-page":"3371","article-title":"Lipoic acid improves survival in transgenic mouse models of Huntington\u2019s disease","volume":"12","author":"Andreassen","year":"2001","journal-title":"Clin. Neurosci."},{"issue":"46","key":"10.1016\/j.phrs.2019.104371_bib0920","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington\u2019s disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib0925","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1038\/cddis.2010.94","article-title":"Necrostatin-1 ameliorates symptoms in R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"2","author":"Zhu","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2019.104371_bib0930","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","article-title":"The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington\u2019s disease mouse model","volume":"210","author":"Peng","year":"2008","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0935","doi-asserted-by":"crossref","first-page":"e00140","DOI":"10.1002\/prp2.140","article-title":"VGF and striatal cell damage in in vitro and in vivo models of Huntington\u2019s disease","volume":"3","author":"Noda","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0940","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington\u2019s disease","volume":"30","author":"Masuda","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib0945","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0950","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington\u2019s disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2019.104371_bib0955","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"5","author":"Duan","year":"2003","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib0960","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.20075","article-title":"Paroxetine retards disease onset and progression in huntingtin mutant mice","volume":"55","author":"Duan","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2019.104371_bib0965","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","article-title":"Resveratrol protects against peripheral deficits in a mouse model of Huntington\u2019s disease","volume":"225","author":"Ho","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2019.104371_bib0970","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-\u03b3 agonist rosiglitazone in N171-82Q mouse model of Huntington\u2019s disease","volume":"125","author":"Jin","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104371_bib0975","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington\u2019s disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib0980","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.07.047","article-title":"Efficacy and safety of fasudil in patients with stable angina \u2013 a double blind, placebo-controlled, phase 2 trial","volume":"46","author":"Vicari","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0985","doi-asserted-by":"crossref","first-page":"19","DOI":"10.18632\/aging.101354","article-title":"Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline","volume":"10","author":"Schwarz","year":"2018","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib0990","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/syn.10054","article-title":"Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington\u2019s disease","volume":"44","author":"Lastres-Becker","year":"2002","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib0995","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/jmf.2008.0028","article-title":"Possible neuroprotective effects of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington\u2019s disease","volume":"12","author":"Kumar","year":"2009","journal-title":"J. Med. Food"},{"issue":"7","key":"10.1016\/j.phrs.2019.104371_bib1000","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/1028415X.2016.1147683","article-title":"Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats","volume":"20","author":"Morales-Martinez","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2019.104371_bib1005","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/237207","article-title":"Korean red ginseng extract attenuates 3-nitropropionic acid-induced Huntington\u2019s-like symptoms","volume":"2013","author":"Jang","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.phrs.2019.104371_bib1010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(00)02640-8","article-title":"Dietary arginine alters time of symptom onset in Huntington\u2019s disease transgenic mice","volume":"875","author":"Deckel","year":"2000","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.phrs.2019.104371_bib1015","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington\u2019s disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib1020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nbd.2012.06.026","article-title":"NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease","volume":"48","author":"Pouladi","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib1025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","article-title":"Beneficial effects of rolipram in the R6\/2 mouse model of Huntington\u2019s disease","volume":"30","author":"DeMarch","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"16","key":"10.1016\/j.phrs.2019.104371_bib1030","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1073\/pnas.162362299","article-title":"Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic model of Huntington\u2019s disease","volume":"99","author":"Keene","year":"2002","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib1035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.10614","article-title":"Minocycline and doxycycline are not beneficial in a model of Huntington\u2019s disease","volume":"54","author":"Smith","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2019.104371_bib1040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2018.01.001","article-title":"Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington\u2019s disease","volume":"302","author":"Fatoba","year":"2018","journal-title":"Exp. Neurol."},{"issue":"28","key":"10.1016\/j.phrs.2019.104371_bib1045","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2019.104371_bib1050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.foodres.2004.01.010","article-title":"Antioxidant properties of marigold extracts","volume":"37","author":"Cetkovic","year":"2004","journal-title":"Food Res. Int."},{"key":"10.1016\/j.phrs.2019.104371_bib1055","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","article-title":"HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor","volume":"96","author":"Hanus","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib1060","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","article-title":"Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)","volume":"289","author":"Hillard","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib1065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pbb.2004.08.005","article-title":"Differential effects of naproxen and rofecoxib on the development of hypersensitivity following nerve injury in rats","volume":"79","author":"Padi","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib1070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/13556210500352964","article-title":"Protective effects of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes","volume":"10","author":"Dhir","year":"2005","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib1075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0006-2952(00)00327-0","article-title":"Oxidative derangement in rat synaptosomes induced by hyperglycaemia: restorative effect of dehydroepiandrosterone treatment","volume":"60","author":"Aragno","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib1080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(03)02124-1","article-title":"Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia","volume":"477","author":"Singh","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib1085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2008.03.038","article-title":"Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice","volume":"587","author":"Akula","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib1090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1159\/000064095","article-title":"Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol","volume":"92","author":"Padi","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.phrs.2019.104371_bib1095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2011.11.030","article-title":"Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity","volume":"674","author":"Kumar","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104371_bib1100","first-page":"159","article-title":"Gabapentin attenuates acute hypoxic stress-induced behavioral alterations and oxidative damage in mice: possible involvement of GABAergic mechanism","volume":"46","author":"Kumar","year":"2008","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.phrs.2019.104371_bib1105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(99)00962-3","article-title":"Cyclosporine-A enhances choline acetyltransferase immunoreactivity in the septal region of adult rats","volume":"279","author":"Borlongan","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.104371_bib1110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/096368979900800107","article-title":"Cyclosporine A-induced hyperactivity in rats: is it mediated by immunosuppression, neurotrophism, or both?","volume":"8","author":"Borlongan","year":"1999","journal-title":"Cell Transplant."},{"key":"10.1016\/j.phrs.2019.104371_bib1115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0090-3019(96)00190-5","article-title":"Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism: relevance to neural transplantation","volume":"46","author":"Borlongan","year":"1996","journal-title":"Surg. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104371_bib1120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12640-011-9258-7","article-title":"Protective effect of embelin from Embelia ribes Brum. against transient global ischemia-induced brain damage in rats","volume":"20","author":"Thippeswamy","year":"2011","journal-title":"Neurotoxicol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.104371_bib1125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.nlm.2010.12.001","article-title":"Genistein ameliorates learning and memory deficits in amyloid beta((1-40)) rat model of Alzheimer's disease","volume":"95","author":"Bagheri","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"issue":"8","key":"10.1016\/j.phrs.2019.104371_bib1130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ptr.1486","article-title":"Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease","volume":"18","author":"Kim","year":"2004","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2019.104371_bib1135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1471-4159.2005.03000.x","article-title":"Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochmical evidences","volume":"93","author":"Ahmad","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104371_bib1140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tox.2006.06.018","article-title":"Beneficial effects of hesperidin on lipopolysaccharide-induced hepatotoxicity","volume":"226","author":"Kaur","year":"2006","journal-title":"Toxicology"},{"issue":"3\u20134","key":"10.1016\/j.phrs.2019.104371_bib1145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.lfs.2008.05.013","article-title":"Lycopene attenuates diabetes-associated cognitive decline in rats","volume":"83","author":"Kuhad","year":"2008","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib1150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0976-500X.64532","article-title":"Effect of vitamin E alone and in combination with lycopene on biochemical and histopathological alterations in isoproterenol-induced myocardial infarction in rats","volume":"1","author":"Upaganlawar","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"2","key":"10.1016\/j.phrs.2019.104371_bib1155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.10092","article-title":"Inhibition of autoimmune encephalomyelitis by a tetracycline","volume":"51","author":"Popovic","year":"2002","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.phrs.2019.104371_bib1160","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"issue":"23","key":"10.1016\/j.phrs.2019.104371_bib1165","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","article-title":"A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window","volume":"96","author":"Yrjanheikki","year":"1999","journal-title":"PNAS"},{"issue":"20","key":"10.1016\/j.phrs.2019.104371_bib1170","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11064-008-9779-5","article-title":"The effects of piroxicam in the attenuation of MPP+\/MPTP toxicity in vitro and in vivo","volume":"34","author":"Soliman","year":"2009","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.phrs.2019.104371_bib1175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainresbull.2011.10.007","article-title":"Role of puerarin in the signaling of neuropathic pain mediated by P2X3 receptor of dorsal root ganglion neurons","volume":"87","author":"Xu","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"11","key":"10.1016\/j.phrs.2019.104371_bib1180","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1248\/yakushi.128.1689","article-title":"Protecting mechanism of puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemia-reperfusion injury","volume":"128","author":"Pan","year":"2008","journal-title":"Yakugaku Zasshi[[J Pharma Soc Japan]]"},{"key":"10.1016\/j.phrs.2019.104371_bib1185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12640-010-9201-3","article-title":"Peroxisome proliferator-activated receptor-\u03b3 (PPAR-\u03b3) activation confers functional neuroprotection in global ischemia","volume":"19","author":"Fatehi-Hassanabad","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.phrs.2019.104371_bib1190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuroscience.2011.07.046","article-title":"Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model","volume":"194","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2019.104371_bib1195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mito.2013.01.005","article-title":"Succinobucol versus probucol: higher efficiency of succinobucol in mitigating 3-NP-induced brain mitochondrial dysfunction and oxidative stress in vitro","volume":"13","author":"Colle","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.phrs.2019.104371_bib1200","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ijc.20629","article-title":"Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells","volume":"113","author":"Hussain","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2019.104371_bib1205","doi-asserted-by":"crossref","first-page":"e0139147","DOI":"10.1371\/journal.pone.0139147","article-title":"Food polyphenols fail to cause a biologically relevant reduction of COX-2 activity","volume":"10","author":"Willenberg","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2019.104371_bib1210","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/carcin\/20.10.1945","article-title":"Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages","volume":"20","author":"Liang","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phrs.2019.104371_bib1215","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbrc.2007.08.049","article-title":"Inhibition of p38\/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects","volume":"362","author":"Corona","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.104371_bib1220","first-page":"147","article-title":"Resveratrol inhibits the expression of cyclooxygenase-2 in mammary epithelial cells","volume":"vol. 492","author":"Subbaramaiah","year":"2001"},{"issue":"1\u20134","key":"10.1016\/j.phrs.2019.104371_bib1225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/biof.5520180218","article-title":"Effects of coenzyme Q(10) in Huntington\u2019s disease and early Parkinson's disease","volume":"18","author":"Beal","year":"2003","journal-title":"Biofactors"},{"issue":"9","key":"10.1016\/j.phrs.2019.104371_bib1230","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s11745-008-3208-z","article-title":"Dietary n-3 HUFA affects mitochondrial fatty acid beta-oxidation capacity and susceptibility to oxidative stress in Atlantic salmon","volume":"43","author":"Kjaer","year":"2008","journal-title":"Lipids"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819303330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819303330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:06:37Z","timestamp":1760911597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819303330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":246,"alternative-id":["S1043661819303330"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104371","relation":{},"ISSN":["1043-6618"],"issn-type":[{"type":"print","value":"1043-6618"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxicity models of Huntington\u2019s disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104371"}}